Annual Total Long Term Liabilities
$93.53 M
-$7.44 M-7.37%
31 December 2023
Summary:
Allogene Therapeutics annual total long term liabilities is currently $93.53 million, with the most recent change of -$7.44 million (-7.37%) on 31 December 2023. During the last 3 years, it has risen by +$39.63 million (+73.54%). ALLO annual total long term liabilities is now -7.37% below its all-time high of $100.97 million, reached on 31 December 2022.ALLO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$92.80 M
-$1.74 M-1.84%
30 September 2024
Summary:
Allogene Therapeutics quarterly total long term liabilities is currently $92.80 million, with the most recent change of -$1.74 million (-1.84%) on 30 September 2024. Over the past year, it has increased by +$1.21 million (+1.32%). ALLO quarterly long term liabilities is now -79.11% below its all-time high of $444.20 million, reached on 30 September 2018.ALLO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALLO Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.4% | +1.3% |
| 3 y3 years | +73.5% | +66.3% |
| 5 y5 years | +126.8% | +118.5% |
ALLO Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -7.4% | +73.5% | -8.1% | +66.3% |
| 5 y | 5 years | -7.4% | +126.8% | -8.1% | +118.5% |
| alltime | all time | -7.4% | -79.1% | +3629.9% |
Allogene Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $92.80 M(-1.8%) |
| June 2024 | - | $94.54 M(+0.5%) |
| Mar 2024 | - | $94.09 M(+0.6%) |
| Dec 2023 | $93.53 M(-7.4%) | $93.53 M(+2.1%) |
| Sept 2023 | - | $91.59 M(-1.9%) |
| June 2023 | - | $93.34 M(-1.8%) |
| Mar 2023 | - | $95.02 M(-5.9%) |
| Dec 2022 | $100.97 M(+29.9%) | $100.97 M(+2.3%) |
| Sept 2022 | - | $98.74 M(-2.0%) |
| June 2022 | - | $100.79 M(+39.0%) |
| Mar 2022 | - | $72.53 M(-6.7%) |
| Dec 2021 | $77.72 M | $77.72 M(+39.3%) |
| Sept 2021 | - | $55.81 M(-1.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $56.91 M(+4.6%) |
| Mar 2021 | - | $54.42 M(+1.0%) |
| Dec 2020 | $53.89 M(-3.2%) | $53.89 M(+0.5%) |
| Sept 2020 | - | $53.64 M(-1.1%) |
| June 2020 | - | $54.23 M(-1.7%) |
| Mar 2020 | - | $55.19 M(-0.9%) |
| Dec 2019 | $55.70 M(+35.1%) | $55.70 M(+31.1%) |
| Sept 2019 | - | $42.47 M(+5.2%) |
| June 2019 | - | $40.36 M(-1.3%) |
| Mar 2019 | - | $40.88 M(-0.9%) |
| Dec 2018 | $41.23 M(>+9900.0%) | $41.23 M(-90.7%) |
| Sept 2018 | - | $444.20 M(>+9900.0%) |
| June 2018 | - | $2.49 M |
| Dec 2017 | $0.00 | - |
FAQ
- What is Allogene Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Allogene Therapeutics?
- What is Allogene Therapeutics annual total long term liabilities year-on-year change?
- What is Allogene Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Allogene Therapeutics?
- What is Allogene Therapeutics quarterly long term liabilities year-on-year change?
What is Allogene Therapeutics annual total long term liabilities?
The current annual total long term liabilities of ALLO is $93.53 M
What is the all time high annual total long term liabilities for Allogene Therapeutics?
Allogene Therapeutics all-time high annual total long term liabilities is $100.97 M
What is Allogene Therapeutics annual total long term liabilities year-on-year change?
Over the past year, ALLO annual total long term liabilities has changed by -$7.44 M (-7.37%)
What is Allogene Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of ALLO is $92.80 M
What is the all time high quarterly long term liabilities for Allogene Therapeutics?
Allogene Therapeutics all-time high quarterly total long term liabilities is $444.20 M
What is Allogene Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, ALLO quarterly total long term liabilities has changed by +$1.21 M (+1.32%)